arrow_back Back Filing freshness 20-F FY 2025 SEC EDGAR

download Export Data

Zepp Health Corp

ZEPP

$2.22 ▼ -0.06 (-2.63%) at close

11 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Zepp Health Corp faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $564.8M

Dividend Yield —

Revenue Growth 41.8% ↗

Op. Margin -11.3% ↗

ROIC -8.4% ↗

FCF / Share $-0.10 ↘

Trailing P/E —

Price / Book 2.6x

FCF Yield —

Debt / Equity 0.28

info Valuation on last close. End-of-day price, Nov 5, 2026.

11-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$258.90M

↑ +41.8% —

Net Income Profit after all expenses

$-40.07M

↑ +47.1% —

Operating Margin Operating profit as % of sales

-11.3%

↑ +56.4% 14th

FCF / Share Free cash flow per share

$-0.10

↓ -3.4% —

Long-Term Debt Long-term obligations

$59.48M

↓ -21.0% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Returns

Financial Health ↑

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 7 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗	FY 2018 Dec 31, 2018 20-F ↗	FY 2017 Dec 31, 2017 20-F ↗	FY 2016 Dec 31, 2016 20-F ↗	FY 2015 Dec 31, 2015 20-F ↗
Revenue Growth YoY (%)	41.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+248%)	-48.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-502%)	-41.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-444%)	-38.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-423%)	-0.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-104%)	18.1% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+51%)	57.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+379%)	68.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+470%)	—	—	—
EPS Growth YoY (%)	44.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-123.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	23.5% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	-35.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-58.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	325.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-20.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—
Net Income Growth YoY (%)	47.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-144.1% Weak ↓ Weak Declining Year-over-year change in net income	25.8% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	-38.3% Weak ↓ Weak Declining Year-over-year change in net income	-57.6% Weak ↓ Weak Declining Year-over-year change in net income	67.1% Excellent Excellent Year-over-year change in net income	91.9% Excellent Excellent Year-over-year change in net income	—	—	—
FCF Growth YoY (%)	-3.4% Weak Weak Year-over-year change in free cash flow	N/M	N/M	-170.3% Weak ↓ Weak Declining Year-over-year change in free cash flow	N/M	-80.4% Weak ↓ Weak Declining Year-over-year change in free cash flow	-51.0% Weak Weak Year-over-year change in free cash flow	-3.6% Weak Weak Year-over-year change in free cash flow	—	—	—
Revenue CAGR 3Y (%)	-24.5% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-42.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-29.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-10.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	22.8% Excellent Excellent Compound annual revenue growth over 3 years	46.3% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—
Revenue CAGR 5Y (%)	-23.5% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-26.2% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-7.8% Weak Weak Compound annual revenue growth over 5 years	13.8% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—
EPS CAGR 3Y (%)	—	—	—	—	4.0% Caution Caution Compound annual EPS growth over 3 years	11.9% Good Good Compound annual EPS growth over 3 years	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗	FY 2018 Dec 31, 2018 20-F ↗	FY 2017 Dec 31, 2017 20-F ↗	FY 2016 Dec 31, 2016 20-F ↗	FY 2015 Dec 31, 2015 20-F ↗
Operating Margin (%) (%)	-11.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-156%)	-25.9% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-229%)	-8.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-143%)	-9.9% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-150%)	1.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-92%)	2.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-86%)	10.4% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-48%)	10.0% Caution Caution Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-50%)	8.9% Caution Caution Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-56%)	—	—
Profit Margin (%) (%)	-15.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-203%)	-41.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-376%)	-8.8% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-159%)	-7.0% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-146%)	2.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-85%)	3.6% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-76%)	9.9% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-34%)	9.3% Caution Caution Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-38%)	8.2% Caution Caution Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-45%)	—	—
FCF Margin (%) (%)	-10.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-14.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	11.6% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	-19.2% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-4.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	1.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	6.8% Caution ↓ Caution Declining Free cash flow as a percentage of revenue Optimal: > 10%	18.9% Good Good Free cash flow as a percentage of revenue Optimal: > 10%	10.6% Fair Fair Free cash flow as a percentage of revenue Optimal: > 10%	—	—
FCF / Net Income (x)	0.65x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.34x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-1.32x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	2.76x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-2.02x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.32x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.68x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	2.03x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	1.29x Good Good Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗	FY 2018 Dec 31, 2018 20-F ↗	FY 2017 Dec 31, 2017 20-F ↗	FY 2016 Dec 31, 2016 20-F ↗	FY 2015 Dec 31, 2015 20-F ↗
Return on Invested Capital (%)	-8.4% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-11.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	2.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	4.9% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	19.2% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	16.0% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	63.7% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-5.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	1.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	3.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	11.7% Good → Good Stable Operating profit relative to total assets Optimal: > 10%	11.2% Good Good Operating profit relative to total assets Optimal: > 10%	12.4% Good Good Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-18.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-201%)	-30.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-263%)	-8.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-148%)	-10.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-158%)	4.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-74%)	8.4% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-55%)	23.0% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+24%)	18.8% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	74.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+301%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗	FY 2018 Dec 31, 2018 20-F ↗	FY 2017 Dec 31, 2017 20-F ↗	FY 2016 Dec 31, 2016 20-F ↗	FY 2015 Dec 31, 2015 20-F ↗
Debt to Equity (x)	0.28x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-38%)	0.30x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-34%)	0.34x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-24%)	0.26x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-43%)	0.25x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-45%)	0.02x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-95%)	—	—	—	—	—
Interest Coverage (x)	-23.52x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-530.90x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-4.86x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-7.20x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	2.09x Caution ↓ Caution Declining Operating income divided by interest expense Optimal: > 5x	11.73x Excellent ↓ Excellent Declining Operating income divided by interest expense Optimal: > 5x	2124.78x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	278.49x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$2.43M	$-15.83M	$-13.65M	$-29.35M	$-116.38M	$-339.21M	$-259.00M	$-209.70M	$-56.30M	—	—
Debt / EBITDA (x)	-2.41x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.78x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-5.27x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.95x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	4.98x Weak Weak Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.30x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗	FY 2018 Dec 31, 2018 20-F ↗	FY 2017 Dec 31, 2017 20-F ↗	FY 2016 Dec 31, 2016 20-F ↗	FY 2015 Dec 31, 2015 20-F ↗
Revenue per Share (USD)	$1.02	$0.71	$1.45	$2.44	$3.89	$3.97	$3.43	$2.50	$4.65	—	—
Basic EPS, GAAP (USD)	$-0.16	$-0.29	$-0.13	$-0.17	$0.09	$0.14	$0.34	$0.08	$0.10	—	—
Free Cash Flow per Share (USD)	$-0.10	$-0.10	$0.17	$-0.47	$-0.17	$0.05	$0.23	$0.47	$0.49	—	—
Book Value per Share (USD)	$0.84	$0.97	$1.44	$1.57	$1.82	$1.68	$1.47	$1.24	$0.38	—	—
Tangible Book Value per Share (USD)	$0.75	$0.91	$1.36	$1.46	$1.69	$1.56	$1.42	$1.20	$0.36	—	—
Basic Weighted Avg Shares (shares)	254.43M	258.88M	243.14M	246.28M	252.17M	248.47M	243.65M	211.87M	67.78M	55.61M	50.04M

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗	FY 2018 Dec 31, 2018 20-F ↗	FY 2017 Dec 31, 2017 20-F ↗	FY 2016 Dec 31, 2016 20-F ↗	FY 2015 Dec 31, 2015 20-F ↗
Working Capital (USD)	$6.68M	$56.20M	$161.62M	$187.01M	$279.14M	$312.37M	$274.45M	$213.77M	$64.26M	—	—
LT Debt (USD)	$59.48M	$75.24M	$120.02M	$99.20M	$114.06M	$9.20M	—	—	—	—	—
Total Equity (USD)	$214.53M	$251.59M	$350.88M	$387.48M	$458.27M	$418.43M	$359.21M	$263.39M	$34.70M	—	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗	FY 2018 Dec 31, 2018 20-F ↗	FY 2017 Dec 31, 2017 20-F ↗	FY 2016 Dec 31, 2016 20-F ↗	FY 2015 Dec 31, 2015 20-F ↗
Sales/Revenue/Turnover (USD)	$258.90M	$182.60M	$352.86M	$600.66M	$980.78M	$985.96M	$834.88M	$530.19M	$314.91M	—	—
Depreciation Expense (USD)	$4.54M	$5.02M	$7.69M	$8.50M	$8.14M	$4.16M	$1.35M	$840.00K	$544.00K	—	—
Net Income, GAAP (USD)	$-40.07M	$-75.73M	$-31.02M	$-41.80M	$21.62M	$35.06M	$82.62M	$49.46M	$25.77M	—	—
Operating Cash Flow (USD)	$-25.69M	$-24.39M	$42.60M	$-114.20M	$-36.47M	$24.11M	$61.48M	$102.92M	$36.63M	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 11 years · 11 quarters

Zepp Health Corp

Analytical Summary

11-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ZEPP with peers